Protagonist Therapeutics, Inc.
PTGX
$155.10
$3.682.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 162.85M | 3.78M | -44.38M | -39.34M | -34.77M |
| Total Depreciation and Amortization | 397.00K | 407.00K | -867.00K | 1.60M | 304.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.43M | 13.93M | 10.94M | 7.74M | 9.57M |
| Change in Net Operating Assets | 42.37M | -67.06M | -2.67M | 28.06M | -3.88M |
| Cash from Operations | 219.05M | -48.94M | -36.98M | -1.94M | -28.78M |
| Capital Expenditure | -168.00K | -215.00K | -144.00K | -88.00K | -813.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.26M | 91.11M | 48.96M | -58.47M | 55.62M |
| Cash from Investing | -2.43M | 90.89M | 48.82M | -58.56M | 54.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.74M | 23.37M | 2.84M | 5.66M | 2.93M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.74M | 23.37M | 2.84M | 5.66M | 2.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 226.37M | 65.32M | 14.68M | -54.83M | 28.96M |